CNBC PRO Talks: Morningstar’s chief U.S. strategist on stocks to beat the volatility

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Prescription drugs have weird names. But so do planets in the Star Wars universe. We asked CNBC staffers whether they could tell the difference. 02:04 Fri, Apr 10 20159:30 AM EDT

CNBC’s Jim Cramer said investors should usually wait until high-quality stocks have had a pullback before buying. But sometimes it’s worth buying some stock at the top, especially if a company engages in significant insider buying. Not to be confused with insider trading, insider buying is based on public information and occurs when executives buy…

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Fast Money ‘Fast Money’ traders Dan Nathan and Tim Seymour reveal their 2024 acronym stock groups they are watching. 05:11 Mon, Jan 8 20246:17 PM EST

Internet lingerie startup “Adore Me” aims to disrupt the U.S. lingerie market. One strategy their using, is to crowdsource the designs they bring to market.

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Squawk on the Street John Lavollo, UBS analyst, joins ‘Squawk on the Street’ to discuss the optimism in the housing market in 2024 and outlook for the sector. 03:04 2 hours ago

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Grayscale CEO Michael Sonnenshein joins ‘Squawk Box’ to discuss the SEC’s approval of bitcoin ETFs, the long road to regulatory approval, what it means for Grayscale and crypto at large going forward, and more.